Haematopoietic stem cell transplantation
Showing 1 - 25 of >10,000
Oral Complications After Haematopoietic Stem Cell
Enrolling by invitation
- Stem Cell Transplant Complications
- Oral Complication
- Haematopoietic stem cell transplantation
-
Nijmegen, NetherlandsRadboudumc
Oct 21, 2022
Precision Medicine for Stem Cell Transplantation
Not yet recruiting
- Haematopoietic Stem Cell Transplantation
- Blood sample collection
- Bone marrow aspirate
- (no location specified)
Oct 4, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,
Recruiting
- Leukemia, Myeloid, Acute
- +5 more
- Venetoclax
- +2 more
-
Melbourne, Victoria, AustraliaMelbourne Health
Jun 19, 2022
Allogenomic Mismatch Score Applied to Haplo-identical
Completed
- Stem Cell Transplantation
- Haplo-identical
- Assessment of the Allogenomic Mismatch Score (AMS)
- Assessment of the optimised Allogenomic Mismatch Score (AMS)
-
Vandœuvre-lès-Nancy, FranceAlice Aarnink
Feb 7, 2022
Sickle Cell Disease Trial (Haploidentical stem cell transplantation, Standard medical care)
Not yet recruiting
- Sickle Cell Disease
- Haploidentical stem cell transplantation
- Standard medical care
- (no location specified)
May 23, 2022
Pneumonia Post Haematopoietic Stem Cell Transplantation
Completed
- Pneumonia
- Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaGuangzhou Women and Children's Medical Center
Nov 22, 2021
Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
- Recipients
- Donors
-
Paris, FranceHopital Necker
Nov 19, 2021
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)
Not yet recruiting
- Leukemia
- 90-Yttrium-labelled anti-CD66 monoclonal antibody
- (no location specified)
Aug 16, 2022
Stem Cell Transplantation, Rehabilitation Trial in Aarhus (Multimodal interdisciplinary rehabilitation programme (HAPPY))
Completed
- Stem Cell Transplantation
- Rehabilitation
- Multimodal interdisciplinary rehabilitation programme (HAPPY)
-
Aarhus, DenmarkDep. of Hem. Aarhus Universitetshospital
Nov 2, 2021
Haematological Malignancy Trial in Parkville (Nivolumab Injection)
Active, not recruiting
- Haematological Malignancy
- Nivolumab Injection
-
Parkville, Victoria, AustraliaRoyal Melbourne Hospital
Sep 21, 2021
Graft Vs Host Disease, Haematological Malignancy, Cancer Trial in Hong Kong
Recruiting
- Graft Vs Host Disease
- +2 more
-
Hong Kong, Hong KongDepartment of Ophthalmology, LKS Faculty of Medicine, The Univer
Dec 9, 2021
Leukemia, Myeloid, Acute Trial in Germany (Human Stem Cell Transplantation, Consolidation chemo, i.e. High-dose Cytarabine
Terminated
- Leukemia, Myeloid, Acute
- Human Stem Cell Transplantation
- Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
-
Aachen, Germany
- +18 more
Oct 28, 2021
Home Care in Allogeneic Haematopoietic Stem Cell Transplantation
Not yet recruiting
- Stem Cell Transplant Complications
- +2 more
- Home care
-
Oslo, NorwayDepartment of Haematology, Division of Cancer Medicine, Oslo Uni
Jan 12, 2021
Tumors, Bone Marrow Transplantation Trial in Parkville (Release of Extended Pharmacogenomics Report at Week 1, Release of
Not yet recruiting
- Neoplasms
- Bone Marrow Transplantation
- Release of Extended Pharmacogenomics Report at Week 1
- Release of Extended Pharmacogenomics Report at Week 13
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Dec 19, 2022
Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)
Recruiting
- Autologous Haematopoietic Stem Cell Transplant
- plerixafor + G-CSF
-
China, ChinaInvestigational Sites
May 4, 2022
Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID) Trial in London (genetic, other, drug)
Completed
- Adenosine Deaminase Deficiency
- Severe Combined Immunodeficiencies (SCID)
- Infusion of autologous EFS-ADA LV CD34+ cells
- +3 more
-
London, United KingdomGreat Ormond Street Hospital for Children NHS Foundation Trust
Aug 20, 2021
Cytomegalovirus (CMV) Infection Trial in Worldwide (Letermovir oral granules, Letermovir tablet, Letermovir intravenous)
Active, not recruiting
- Cytomegalovirus (CMV) Infection
- Letermovir oral granules
- +2 more
-
Duarte, California
- +39 more
Jan 9, 2023
Acute Myeloblastic Leukemia, Acute Lymphoblastic Leukemia, Juvenile Myelomonocytic Leukemia Trial in London (Yttrium-90 labelled
Completed
- Acute Myeloblastic Leukemia
- +2 more
- Yttrium-90 labelled monoclonal antibody against CD66
-
London, United KingdomGreat Ormond Street Hospital for Children
Jun 24, 2021
Donor CHIP and Allogeneic HSCT Outcome
Recruiting
- Clonal Hematopoiesis
- Next generation sequencing
-
Hong Kong, Hong KongThe University of Hong Kong
Dec 29, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))
Terminated
- AIDS-related Lymphoma
- HIV Infections
- PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 4, 2022